The impact of new topical corticosteroids on the management of atopic dermatitis;El impacto de los nuevos corticosteroides tópicos en el tratamiento de la dermatitis atópica

Actas Dermo-Sifiliograficas

Volumn 92, Issue 11, 2001, Pages 483-488

  De Los Ángeles Guerra Tapia, Aurora ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Aceponate; Allergic contact dermatitis; Atopic dermatitis; Budesonide; Corticosteroids; Fluticasone propionate; Methylprednisolone; Mometasone furoate; New corticosteroids; Prednicarbate

Indexed keywords

BUDESONIDE; CORTICOSTEROID; CYCLOSPORIN; FLUTICASONE PROPIONATE; METHYLPREDNISOLONE ACEPONATE; MOMETASONE FUROATE; PREDNICARBATE;

ATOPIC DERMATITIS; CLINICAL TRIAL; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG SENSITIVITY; DRUG TRANSFORMATION; HUMAN; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN ALLERGY; TREATMENT INDICATION;

EID: 0005269848     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Hanifin JM, Chan S. Biochemical and immunologic mechanisms in atopic dermatitis: new targets for emerging therapies. J Am Acad Dermatol 1999;41:72-7.
2. Fleicher AB. Treatment of atopic dermatitis role of tacrolimus ointment as a topical noncorticosteroidal therapy. J Allergy Clin Immunol 1999;104:S126-S130.
3. Van Leent EJ, Graber M, Thurston M, Wagenaar A, Supls PI, Bos KD. Effectiveness of the ascomycin macrolactam SDZ AMS 981 in the topical treatment of atopic dermatitis. Arch Dermatol 1998;134:805-9.
4. Haniffin JM, Scheneider LC, Leung DYM, Ellis GN, Jaffe HS, Izn AE, y cols. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28:189-97.
5. Hench PS, Kendall EC, Slocumb CH. The effect of a hormone of the adrenal cortex and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin Proc 1949;24:181-93.
6. Sulzberguer MB, Witten VH. The effect of topically applied compound F in selected dermatosis. J Invest Dermatol 1952;19:101-2.
7. Thalen A, Brattsand R. Synthesis and antiinflamatory properties of budesonide, a new halogenated corticoid with high local activity Arnzeim Forsch Drug Res 1979;29:1687-90.
8. Corazza M, Mantovani L, Maranini C, Bacilieri S, Virgili A. Contact sensitization to corticosteroids: increased risk in long term dermatosis. Eur J Dermatol 2000;10:533-5.
9. Rosenthal D, Duke E. A clinical investigation of the efficacy and safety of mometasone furoate ointment 0,1% vs betamethasone valerate ointment 0,1% in the treatment of psoriasis. Curr Ther Res 1988;44:790-800.
10. Koivukangas V, Karvonen J, Risteli J, Oikarinen A. Topical mometasona furoate and betamethasone-17-valerate decrease collagen synthesis to a similar extent in human skin in vivo. Br J Dermatol 1995;132:66-8.
11. Keliner HM, Eckert HG, Fechlhaber HW, Hornke I, Ocknomopulos R. Invetiations of the farmacokineties of the local corticosteroid prednicarbateand its biotransformation after topical application. Z Hautkr 1986;61 (suppl 1):18-21.
12. Iglesias L, Guerra A, Ledo A. Ensayo clínico comparativo intraindividual, aleatorizado y doble ciego entre dos corticosteroides tópicos, prednicarbato y diflucortolona, en el tratamiento de la psoriasis. Actas XXIII Congreso Nacional de la Academia Española de Dermatología y Venereología. Madrid, 16-18 de junio de 1994.
13. Degreef H. New corticosteroids. Skin Therapy Lelt 1999; 4:1-5.
14. Degreef H, Dooms-Goossens A. The new corticosteroids: are they effective and safe? Dermatol Clin 1993;11:155-60.
15. Matsuda K, Katsunuma M, Iikura Y, Kato H, Saito H, Akasawa A. Adrenocortical function in patients with severe atopic dermatitis. Ann Allergy Asthma Immunol 2000; 85(1):35-9.
16. Lauerma AI, Reitamo S. Conytact allergy to corticosteroids. J Am Acad Dermatol 1993;18:618-22.
17. Chew AL, Maibacha HI. Multiple corticosteroid orally elicited allegic contact dermatitis in a patient with multiple topical corticosteroid allergic contact dermatitis. Cutis 2000;65:307-11.
18. Guerra Tapia, A. Dermatitis atópica. Biblioteca de Dermatología pediátrica. Madrid: Ed. Grupo Aula Médica, SA; 1995.
19. Ortiz de Frutos J, Guerra Tapia A, Gómez A, De la Cruz J, Álvarez DG, De la Mano D. Validación de la versión española del cuestionario del grupo de trabajo sobre la dermatitis atópica del Reino Unido. Rev Clín Española 1998; 198:424-8.
20. Guerra Tapia A. Dermatitis atópica. Monografías de Pediatría 1998;112:3-30.
21. Hoare C, Li Wan PO A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4:1-191.
22. Fukaya M. Why do patients with atopic dermatitis refuse to apply topical corticosteroids? Dermatology 2000;201:242-5.
23. Hanifin JM, Tofte SJ. Update on therapy of atopic dermatitis. J Allergy Clin Immunol 1999;104:S123-S125.
24. Ainley-Waler PF, Patel K, David TJ. Side to side coparison of topical treatment in atopic dermatitis. Arch Dis Clin 1998;79:149-52.
25. Pershing LK, Corien H, Lambert LD, Poncelet CE. Circadian activity of topical 0,05% betamethasone dipropionate in human skin in vivo. J Invest Dermatol 1994;102:734-9.